Mirum Pharmaceuticals is a company creating therapies for patients with liver diseases. The company specializes in Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC). It aims to address the underlying cause of symptoms and liver damage with the approach based on data from clinical trials.